Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More

Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
The global race to secure a steady supply of critical minerals has taken an unexpected turn following a groundbreaking discovery…
Read More
A collaborative research initiative led by the University of the Witwatersrand (Wits) in South Africa and Huzhou University in China…
Read More
Off the northwestern coast of mainland Europe, an island nation with significant ambitions for its life sciences sector is navigating…
Read More
Utrecht, Netherlands – Vitestro, a pioneering medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an…
Read More
Abselion, a pioneering life sciences technology company headquartered in Cambridge, UK, dedicated to streamlining biomolecule quantification, has announced the strategic…
Read More
In an era defined by the escalating environmental toll of synthetic polymers, a breakthrough in materials science has emerged from…
Read More
Sanofi has entered into an exclusive global license agreement with Kali Therapeutics, a significant move that grants the pharmaceutical giant…
Read More
In a landmark achievement for the field of particle physics, researchers at Indiana University (IU) have contributed to a significant…
Read More
In a comprehensive analytical study that addresses one of the most persistent challenges in mechanical engineering and environmental science, researchers…
Read More